NCT07334938

Effects of Far Infrared Rays and Transcutaneous Electrical Nerve Stimulation on Short Term Prognosis of Head and Neck Cancer Patients Receiving Curative Treatment

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Buddhist Tzu Chi General Hospital · Academic / Other
• Sex: All
• Age: 30 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to determine whether far-infrared therapy and transcutaneous electrical nerve stimulation (TENS) can improve postoperative side effects in patients with head and neck cancer. The main questions this study aims to answer are: Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce pain and improve neck range of motion? Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce inflammation? Researchers will compare three groups: Group A: control group; Group B: transcutaneous electrical nerve stimulation; Group C: far-infrared therapy combined with transcutaneous electrical nerve stimulation, to evaluate differences in pain, neck range of motion, and inflammation. Participants will receive the assigned intervention in the morning and evening for five consecutive days. Outcome measurements will be conducted on the first and fifth days.

Conditions

• Head and Neck Cancer (H&N)

Interventions

Type	Name	Description
DEVICE	Transcutaneous Electrical Nerve Stimulation (TENS)	Transcutaneous electrical nerve stimulation is applied to the neck region twice daily, in the morning and evening, for five consecutive days.
DEVICE	Far-Infrared Therapy	Far-infrared therapy is applied to the neck region twice daily, in the morning and evening, for five consecutive days.

Timeline

• Start date: 2024-05-01
• Primary completion: 2025-11-30
• Completion: 2026-03-31
• First posted: 2026-01-12
• Last updated: 2026-01-13

Locations

1 site across 1 country: Taiwan